Using the iconPCR system, n6 presents enhancements in low-pass whole genome sequencing. This approach enables balanced, ...
Ultima Genomics has transformed highly efficient, production-scale sequencing while reducing the sequencing cost per genome ...
Community-acquired pneumonia is a major global health challenge that disproportionately affects vulnerable populations, ...
The "Automated Liquid Handling Systems Market Industry Trends and Global Forecasts to 2035: Distribution by Pipetting Technology, Washing Technology, Modality Type of Instrument, Application, End User ...
The automated liquid handling systems market presents growth opportunities driven by biopharmaceutical advancements, with ...
Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results